微管相互作用和贩运域含有1个缺陷导致通过组织因子介导的凝血在膀癌中的生存率较低
Yuanbin Chen1, Wei Jiao2, Yonghua Wang2
1Qingdao Clinical Medical Research Center for Urinary System Disease, The Affiliated Hospital of Qingdao University, Qingdao, China.
Journal of thrombosis and haemostasis : JTH
|March 30, 2024
概括
膀癌预后基因,如MITD1,促进高凝血和转移. 向MITD1可能为癌症相关的血栓形成提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 癌症患者面临高凝血和静脉血栓栓塞的风险增加.
- 膀癌中高凝血的机制以及抗凝血剂治疗对预后的影响仍然不清楚.
研究的目的:
- 研究预后基因在膀癌通过瘤介导凝血进展中的作用.
- 确定关键的预后基因并阐明它们对高凝血的影响.
主要方法:
- 利用癌症基因组图谱,基因表达总汇和ArrayExpress数据集来识别预后基因.
- 进行免疫组织化学,基因淘汰,下一代测序和细胞/动物实验,以验证发现并评估基因功能.
- 研究了微管相互作用和含有1 (MITD1) 的流通域在凝血中的作用.
主要成果:
- 含有1 (MITD1) 的微管相互作用和贩运域被确定为膀癌的主要预后基因.
- MITD1 枯竭显著增加了组织因子 (TF) 表达,促进细胞动力学停止,展开蛋白质反应和c-Jun激活.
- 在实验模型中,MITD1缺乏的细胞表现出增强的凝血和转移.
结论:
- 瘤预后基因在发展高凝血表型和静脉血栓栓塞症方面发挥着重要作用.
- 向MITD1为膀癌提供了潜在的治疗策略,解决瘤进展和相关的血栓形成风险.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


